title: Is experimental endotoxaemia in humans suitable for simulating antibiotic pharmacokinetics in sepsis and septic shock? A pilot study using the model compound fosfomycin.
authors.forename: Robert
authors.initials: R
authors.lastname: Sauermann
authors.forename: Bernhard X
authors.initials: BX
authors.lastname: Mayer-Helm
authors.forename: Martina
authors.initials: M
authors.lastname: Petsch
authors.forename: Martin
authors.initials: M
authors.lastname: Popovic
authors.forename: Christiane
authors.initials: C
authors.lastname: Thallinger
authors.forename: Christian
authors.initials: C
authors.lastname: Joukhadar
mesh_terms: D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D019446:Endotoxemia; D005578:Fosfomycin / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans; D008070:Lipopolysaccharides / Q000008:administration & dosage; D008297:Male; D010865:Pilot Projects; D018805:Sepsis / Q000188:drug therapy*; D012772:Shock, Septic / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D008070:Lipopolysaccharides; D005578:Fosfomycin